How can a plant that isn’t cannabis interact with cannabinoid receptors? The answer starts with beta-caryophyllene: an aromatic plant compound with a surprisingly interesting role in both plant ecology and human biology.
You’ll find it in cannabis, but also in black pepper, cloves and copaiba. These plants share a molecule that can activate a receptor in our own endocannabinoid system.
To understand why that matters, it helps to follow the story from the plant itself, through the chemistry of its aromatic compounds, to the way cells receive and respond to molecular signals.
What is beta-caryophyllene?
Beta-caryophyllene, also written as β-caryophyllene or BCP, belongs to the terpene family. Terpenes are compounds that contribute to the aromas of many plants, including herbs, spices and cannabis.
More specifically, it is a sesquiterpene: a terpene built from a framework of 15 carbon atoms. You don’t need to memorise the chemistry, but that structure matters. A molecule’s three-dimensional shape and chemical properties help determine which biological targets it can interact with.
In black pepper, beta-caryophyllene is one of several compounds in its aromatic profile. Pepper’s heat comes mainly from piperine, while its aroma involves a mixture of volatile compounds. That is a useful distinction: the compounds we smell and the compounds responsible for a food’s pungency can be different.
Why do plants make terpenes?
Terpenes contribute to a plant’s interactions with its surroundings. Depending on the compound and the species, they can help with defence and chemical communication.
Beta-caryophyllene offers a fascinating example. Researchers studying certain maize varieties found that roots damaged by root-feeding insects released it into the surrounding soil. The compound attracted tiny organisms called nematodes that attack those insect larvae.
In that setting, the terpene helped recruit the plant’s own pest-control support. Researchers also investigated its role in attracting natural enemies of insects above ground.
That gives us a richer way to think about aromatic plant chemistry. The scent we notice can be part of a molecule’s much wider ecological story.
One molecule, several very different plants
Plants from different botanical families can produce the same compound. When we identify beta-caryophyllene in copaiba and cannabis, we are identifying the same molecule within different mixtures.
Black pepper
The dried fruits of Piper nigrum contain a complex mixture of aromatic compounds. Beta-caryophyllene sits alongside others such as limonene and pinene in studied pepper samples.
Cloves
Cloves are the dried flower buds of Syzygium aromaticum. They contain beta-caryophyllene alongside eugenol, a major contributor to their familiar clove character.
Copaiba
South American trees in the Copaifera genus produce an oil-resin called an oleoresin. Its volatile portion can contain substantial amounts of beta-caryophyllene.
Cannabis adds another example of this shared chemistry. Its terpene profile exists alongside other constituents, including cannabinoids. Each plant combines its compounds in different proportions.
Our bodies have their own cannabinoid signalling system
The endocannabinoid system is part of our own biology. It includes signalling molecules made by the body, receptors that respond to them, and enzymes involved in their production and breakdown.
Two well-known internal messengers are anandamide and 2-AG. They help carry signals between cells as part of the body’s regulation of physiological activity.
The two best-known cannabinoid receptors are CB1 and CB2. CB1 is abundant in the brain and nervous system. CB2 is particularly associated with immune cells, including the brain’s immune cells, called microglia.
These receptors function whether or not someone uses cannabis. Plant compounds enter the story because some can interact with this existing system.
How does beta-caryophyllene activate CB2?
A receptor is a protein that receives a molecular signal. When a compatible molecule binds to it, it can change the receptor’s shape and influence activity inside the cell.
CB2 belongs to a family called G protein-coupled receptors. These connect signals received at the cell surface with internal signalling machinery. That machinery can influence how the cell responds and which chemical messengers it produces.
Beta-caryophyllene has been shown to bind to and activate CB2. Researchers call a receptor-activating compound an agonist. Its activity is selective for CB2 compared with CB1, the receptor central to THC’s intoxicating effects.
So how can a plant that isn’t cannabis do this?
Receptors respond to molecular chemistry. Beta-caryophyllene has the same chemical identity whether it comes from black pepper, copaiba or cannabis. Its ability to interact with CB2 comes from the molecule itself.
Why are researchers interested in CB2?
Immune cells communicate through chemical messengers, including proteins called cytokines. These help coordinate immune responses and inflammation.
CB2 activation can influence this signalling. The response depends on the cell, the activating compound and the experimental conditions, which makes it a subject of research into immune regulation.
This is more specific than simply “boosting immunity”. Scientists are investigating how particular signals change cellular behaviour, including whether they can reduce excessive inflammatory activity in certain settings.
Research into beta-caryophyllene therefore extends beyond its aroma to questions about immune signalling, inflammation and pain sensitivity.
What have scientists actually observed?
Evidence linking beta-caryophyllene to CB2
A landmark 2008 study demonstrated its CB2 activity and examined its effects in experimental inflammation. In mice with functioning CB2 receptors, oral beta-caryophyllene reduced an induced inflammatory response. That effect was absent in mice lacking CB2.
The comparison mattered: it helped link the observed response to the receptor, rather than merely showing that something changed after administering the compound.
Changes in pain sensitivity in mice
A study published in 2014 investigated beta-caryophyllene in mouse models of inflammatory and nerve-related pain. Repeated oral administration in a nerve injury model reduced exaggerated sensitivity to heat and pain responses to normally non-painful mechanical stimulation.
The researchers also reported reduced inflammatory activity in the spinal cord. These findings gave them a reason to investigate the relationship between CB2 signalling, inflammation and pain processing further.
Whole copaiba oil behaved differently from its main terpene
In a 2020 cultured-cell study, researchers compared copaiba essential oil with isolated beta-caryophyllene. For one signalling pathway involved in cellular growth and metabolism, the whole oil increased activity while the isolated compound decreased it.
The researchers concluded that the oil’s effects involved multiple constituents and CB2-related signalling. It is an interesting example of how a complex preparation can behave differently from one of its major ingredients. It does not establish that the whole oil is clinically better.
Where do CBD and THC fit into the picture?
These compounds are often mentioned together because of their connections to cannabis and the endocannabinoid system. Their receptor relationships help explain why researchers study them individually.
| Compound | Relationship with cannabinoid receptors |
|---|---|
| Beta-caryophyllene | A terpene that directly activates CB2, with selectivity over CB1. |
| CBD | A cannabinoid with low affinity for the main binding sites of CB1 and CB2. Its biological actions are complex and involve several targets. |
| THC | A cannabinoid that activates CB1 and CB2. Its activity at CB1 is central to its intoxicating effects. |
The term “dietary cannabinoid”, used in the 2008 beta-caryophyllene paper, describes its receptor activity and occurrence in food plants. Chemically, beta-caryophyllene is a terpene. That gives it an interesting place in both conversations.
From an interesting mechanism to a useful treatment
The studies above reveal measurable biological activity. Establishing a treatment benefit in people requires further work on dose, absorption, safety and clinical outcomes.
A food containing beta-caryophyllene, an isolated research compound and a distilled essential oil deliver different mixtures and concentrations. The route of use matters too: swallowing, inhaling and applying a preparation to skin are different forms of exposure.
Current evidence does not establish copaiba essential oil as a treatment for CRPS or other nerve pain conditions. Essential oils can irritate skin and may be harmful if swallowed; follow the product’s intended use and safety directions, and seek clinical advice about use for a medical condition.
The botanical connection worth remembering
Beta-caryophyllene has a story that stretches from plant defence to the pepper grinder and into receptor biology. It shows how one molecule can play different roles in different living systems.
For us, that makes it a compelling part of hemp education. Understanding cannabis also means exploring the wider world of plants it shares its chemistry with—and the body’s own signalling systems that make those connections possible.
Keep exploring the Hemp Hub
Curious about hemp, plant ingredients and the science behind them? Explore more articles in the Hemp Hub.
Sources & further reading
- Gertsch et al. (2008): Beta-caryophyllene is a dietary cannabinoid — CB2 binding and experimental inflammation.
- Köllner et al. (2008): Beta-caryophyllene and indirect defence in maize — its role as a plant defence signal.
- Jirovetz et al. (2002): Aroma compound analysis of pepper essential oils — aromatic compounds in pepper samples.
- Phytochemical profiling of clove and black pepper (2024) — compounds in familiar culinary spices.
- Development of a gas chromatography method for copaiba oil (2017) — extraction and essential oil composition.
- Veiga Junior et al. (2007): Comparative study of three copaiba oleoresins — differences in composition between samples.
- University of Sydney, Lambert Initiative: Endocannabinoids — the body’s own messengers and receptors.
- CB2 signalling and cytokine secretion in human immune cells (2020) — the complexity of receptor-mediated immune regulation.
- Klauke et al. (2014): Beta-caryophyllene in mouse models of inflammatory and neuropathic pain — preclinical pain research.
- Urasaki et al. (2020): Copaiba essential oil and neuronal signalling pathways — comparison of whole oil with isolated beta-caryophyllene in cultured cells.
- Thomas et al. (2007): CBD and cannabinoid receptor activity — CBD’s distinct receptor behaviour.
- Poison Control: Essential oil safety — skin exposure and ingestion.
A note from Made In Hemp: We are licensed industrial hemp growers and a family business with a long-standing interest in hemp. This article shares general educational information, not medical advice. Discuss treatment decisions with your qualified healthcare professional.